1、White PaperMitigating Risk and Disruption in the MedTech Sector An IQVIA MedTech Canada perspective on navigating the trade uncertaintiesDHEEMAN VAIDYA,Director,Business Development,IQVIA MedTech ANASTASIA CHERNYATINA,Senior Consultant,IQVIA MedTechTable of contentsExecutive summary 1Potential impac

2、t of new tariffs on MedTech 1Canada:Impacts on various device categories 3Canada and the United States:Impact on MedTech manufacturers 5Canada:Resilience in the MedTech market 6Canada:Insights for navigating disruptive MedTech market change 6Short-to medium-term strategies 6Medium-to long-term strat

3、egies 9Conclusion 9IQVIA MedTech provides a data-driven methodology to assist companies in managing uncertainty effectively 10References 12 About the authors 14 |1Supply chainissuesWar conflictsGlobal tariffsMedtech sectorrisksExecutive summary The MedTech sector is currently facing a period of ongo

4、ing risk and disruption.Recent challenges have included the global semiconductor shortage and other supply chain issues triggered by the COVID-19 pandemic,as well as events in the Gulf and Ukraine.Most recently,trade issues have arisen due to swift U.S.trade policy changes and the imposition of tari

5、ffs on goods from Canada,Mexico,and China.These tariffs,along with potential retaliatory measures,pose a risk to the MedTech sector due to its complex supply chain,which relies heavily on offshore manufacturing.1 The result is likely to be increased costs for medical devices,negatively affecting hea

6、lthcare and reducing sales outside of the U.S.2 Authored by IQVIA MedTech experts,this paper explores the potential impact of tariffs on the Canadian MedTech market and outlines strategies for manufacturers to consider.Key steps include undertaking scenario and sensitivity analyses,as well as formul